Your browser doesn't support javascript.
loading
Targeting PIN1 exerts potent antitumor activity in pancreatic ductal carcinoma via inhibiting tumor metastasis.
Chen, Linying; Xu, Xiao; Wen, Xinxin; Xu, Shenmin; Wang, Long; Lu, Wenxian; Jiang, Mingting; Huang, Jing; Yang, Dayun; Wang, Jichuang; Zheng, Min; Zhou, Xiao Zhen; Lu, Kun Ping; Liu, Hekun.
Afiliación
  • Chen L; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Xu X; Department of Pathology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.
  • Wen X; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Xu S; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Wang L; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Lu W; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Jiang M; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Huang J; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Yang D; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Wang J; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Zheng M; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Zhou XZ; Fujian Key Laboratory for Translational Research in Cancer and Neurodegenerative Diseases, Institute for Translational Medicine, The School of Basic Medical Sciences, Fujian Medical University, Fuzhou, China.
  • Lu KP; Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
  • Liu H; Division of Translational Therapeutics, Department of Medicine and Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA.
Cancer Sci ; 110(8): 2442-2455, 2019 Aug.
Article en En | MEDLINE | ID: mdl-31148345
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Peptidilprolil Isomerasa de Interacción con NIMA / Metástasis de la Neoplasia / Antineoplásicos Límite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2019 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Pancreáticas / Carcinoma Ductal Pancreático / Peptidilprolil Isomerasa de Interacción con NIMA / Metástasis de la Neoplasia / Antineoplásicos Límite: Animals / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Sci Año: 2019 Tipo del documento: Article País de afiliación: China